Avanos Recalls Ballard Closed Suction Systems
Due to sterilization failureMay result in non-sterile devices
Avanos Medical, Inc. is recalling its Ballard Closed Suction Systems after identifying a failure in the sterilization process, which may result in non-sterile devices. Use of these products could lead to serious health risks, including infection, airway injury, inflammation, sepsis, or death.
No injuries or deaths have been reported to date.
About the Device
The Ballard Closed Suction System is used for removing airway secretions in ventilated patients, helping to maintain ventilation without disconnecting the circuit — a critical function in respiratory care.
Recommended Actions (as of March 19, 2025)
- Immediately stop using any affected products and quarantine them.
- Check your inventory for affected items listed in the recall notice.
- Notify any customers or departments you may have shared the product with.
- Complete and return the Response Form to: productquality@myairlife.com.
- Arrange for return or confirm destruction of affected units to receive replacements.
- Communicate the recall to all relevant staff within your organization.
- For urgent replacement needs, contact AirLife at 1-800-433-2797.
Need Help?
For questions or support related to the recall, contact Avanos Medical, Inc. at 1-800-433-2797.
Healthcare providers are urged to act promptly to prevent potential harm to patients relying on these critical airway management systems.
Affected Products
Affected Product
Product Names:
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Y-Adapter
- Ballard Closed Suction System for Neonates/Pediatrics, 10 F, Elbow
- Ballard Closed Suction System for Neonates/Pediatrics, 8 F, Elbow
- Ballard Closed Suction System for Adults, 14 F, T-Piece
- Ballard Closed Suction System for Adults, 14 F, DSE
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE, MDI
- Ballard Turbo-Cleaning Closed Suction System for Adults, 14 F, DSE
Click here to see a full list of affected devices.
Pharmacal Recalls MG217 Eczema Cream
Pharmacal Recalls MG217 Eczema Cream Due to Staphylococcus aureus ContaminationFDA posts nationwide recall after microbial contamination found in topical skin treatment Pharmacal has voluntarily recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin...
Cefazolin Injection Recalled Due to Cardboard in Sterile IV Solution
Baxter Recalls Cefazolin Injection Sterile IV SolutionCardboard Particulate Matter Found in a Sterile Intravenous Infusion Bag Baxter International has voluntarily recalled one lot of Cefazolin in Dextrose Injection, USP, 2 g/100 mL after a report of cardboard...
FDA Early Alert for Baxter Intravascular Administration Sets
Healthcare facilities are instructed to immediately stop using affected IV solution sets while FDA evaluates the potentially high-risk device issueThe U.S. Food and Drug Administration (FDA) has issued an Early Alert regarding certain Baxter Duo-Vent Solution Sets...